Fluoxetin-induced pulmonary granulomatosis

European Respiratory Journal

Volumn 9, Issue 3, 1996, Pages 615-617

  De Kerviler, E ^a   Tredaniel J ^a   Revlon, G ^a   Groussard, O ^b   Zalcman, G ^a   Ortoli, J M ^a   Espie M ^a   Hirsch, A ^a   Frija, J ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

effect of drugs, lung; fluoxetine, lung; granuloma, lung; nodules

Indexed keywords

FLUOXETINE;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG GRANULOMATOSIS; LUNG NODULE; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUOXETINE; GRANULOMA, GIANT CELL; HUMANS; LUNG DISEASES; MIDDLE AGED;

EID: 0029926888     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09030615     Document Type: Article

References (8)

1. Rosenow III E, Myers J, Swensen S, Pisani R. Drug-induced pulmonary disease: an update. Chest 1992; 102: 239-250.
2. Cooper J, White D, Matthay R. Drug-induced pulmonary disease. Part 2. Noncytotoxic drugs. Am Rev Respir Dis 1986; 133: 488-505.
3. Gregory S, Grippi M. The clinical diagnosis of drug-induced pulmonary disorders. J Thorac Imag 1991; 6: 8-18.
4. Rosenow III E. The spectrum of drug-induced pulmonary disease. Ann Intern Med 1972; 77: 977-991.
5. Akoun G, Milleron B, Cadranel J, Mayaud C, Pneumopathies médicamenteuses. In: Godard P, Bousquet J, Mayaud C, eds. Maladies Respiratoires. Masson, 1993; 791-797.
6. Bass S, Colebatch H. Fluoxetine-induced lung damage. Med J Aust 1992; 156: 364-365.
7. Wernicke J. The side effect profile and safety of fluoxetine. J Clin Psychiatry 1985; 46: 59-67.
8. Pietra G. Pathologic mechanisms of drug-induced lung disorders. J Thorac Imag 1991; 6: 1-7.